Efficacy and safety of subcutaneous immunotherapy with house dust mite for allergic rhinitis: A Meta-analysis of Randomized Controlled Trials

Allergy. 2019 Jan;74(1):189-192. doi: 10.1111/all.13583. Epub 2018 Aug 29.

Authors

Yanran Huang^{1

2}, Chengshuo Wang^{1

2}, Xiangdong Wang^{1

2}, Luo Zhang^{1

2

3}, Hongfei Lou^{1

2}

Affiliations

¹ Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, China.
² Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, China.
³ Department of Allergy, Beijing TongRen Hospital, Capital Medical University, Beijing, China.

PMID: 30074245
DOI: 10.1111/all.13583

No abstract available

Publication types

Letter
Meta-Analysis
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Animals
Child
Humans
Immunotherapy / adverse effects
Immunotherapy / methods*
Injections, Subcutaneous
Pyroglyphidae / immunology*
Randomized Controlled Trials as Topic*
Rhinitis, Allergic / therapy*